Heart fatty acid binding protein in the diagnosis of myocardial infarction: Where do we stand today?

Cardiology

Volumn 108, Issue 1, 2007, Pages 4-10

  Colli, Andrea ^a,b   Josa, Miguel ^b   Pomar, Jose Luis ^b   Mestres, Carlos Alberto ^b   Gherli, Tiziano ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cardiac markers; Heart fatty acid binding protein; Myocardial infarction

Indexed keywords

CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; FIBRINOLYTIC AGENT; HEART FATTY ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; CORONARY ARTERY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HEART SURGERY; HUMAN; KIDNEY CLEARANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RELIABILITY; REVIEW; THORAX PAIN; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 34347405137     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095594     Document Type: Review

References (91)

1. Bassingthwaighte JB, Noodleman L, Van der Vusse GJ, Glatz JF: Modeling of palmitate transport in the heart. Mol Cell Biochem 1989;88:51-58.
2. Peeters RA, Veerkamp JH, Demel RA: Are fatty acid binding proteins involved in fatty acid transfer? Biochim Biophys Acta 1989;1002:8-13.
3. Ockner RK, Manning JA, Poppenhausen RB, Ho WK: A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues. Science 1972;177:56-58.
4. Ando S, Xue XH, Tibbits GF, Haunerland NH: Cloning and sequencing of complementary DNA for fatty acid binding protein from rainbow trout heart. Comp Biochem Physiol Biochem Mol Biol 1998;119:213-217.
5. Bass NM: The cellular fatty acid binding proteins. Aspects of structure, regulation, and function. Int Rev Cytol 1988;111:143-184.
6. Clarke SD, Armstrong MK: Cellular lipid binding proteins: expression, function, and nutritional regulation. FASEB J 1989;3:2480-2487.
7. Glatz JF, Veerkamp JH: Intracellular fatty acid-binding proteins. Int J Biochem 1985;17:13-22.
8. Okner RK: Historic overview of studies on fatty acid-binding proteins. Mol Cell Biochem 1990;98:3-9.
9. Paulussen RJ, Van der Logt Cp, Veerkamp JH: Characterization and binding properties of fatty acid-binding proteins from human, pig and rat heart. Arch Biochem Biophys 1988;264:533-545.
10. Sweetser DA, Heuckeroth RO, Gordon JA: The metabolic significance of mammalian fatty acid-binding proteins: abundant proteins in search of a function. Ann Rev Nutr 1987;7:337-357.
11. Veerkamp JH, Peeters RA, Maatman RG: Structural and functional features of different types of cytoplasmatic fatty acid-binding proteins. Biochim Biophys Acta 1991;1081:1-24.
12. Veerkamp JH, Paulussen RJ, Maatman RG, van Moerkerk HT, Van Kuppevelt TH: Detection, tissue distribution and(sub) cellular localization of fatty acid-binding protein types. Mol Cell Biochem 1990;98:11-18.
13. Glatz JF, van der Vusse GJ: Nomenclature of fatty acid-binding proteins. Mol Cell Biochem 1990;98:231-235.
14. van der Vusse GJ, Glatz JF, Stam HC: Myocardial fatty acid homeostasis. Mol Cell Biochem 1989;88:1-6.
15. Potter BJ, Sorrentino D, Berk PD: Mechanisms of cellular uptake of free fatty acids. Ann Rev Nutr 1989;9:253-270.
16. Borchers T, Hohoff C, Buhlmann C, Spener F: Heart-type fatty acid binding protein involvement in growth inhibition and differentiation. Prostaglandins Leukot Essent Fatty Acids 1997;57:77-84.
17. Burton PB, Hogben CE, Joannou CL, et al: Heart fatty acid binding protein is a novel regulator of cardiac myocites hypertrophy. Biochem Biophys Res Commun 1994;205:1822-1828.
18. Fournier NC, Zucker M, Williams RE, Smith IC: Self association of the cardiac fatty acid binding protein. Biochemistry 1985;24:2387-2396.
19. Fournier NC, Rahim M: Control of energy production in the heart: a new function for fatty acid binding protein. Biochemistry 1985;24:2387-2396.
20. Fournier NC, Richard MA: Fatty acid binding protein, a potential regulator of energy production in the heart. Investigation of mechanisms by electron spin resonance. J Biol Chem 1988;263:14471-14479.
21. Gotz FM, Thole HH: Smooth muscle fatty acid binding protein: a regulator of smooth muscle contractions? Biol Chem 1996;377:633-638.
22. Niot I, Poirier H, Besnard P: Regulation of gene expression by fatty acids: Special reference to fatty acid-binding protein (FABP). Biochimie 1997;79:129-133.
23. Troxler RF, Offner GD, Jiang JW, et al: Localization of the gene for human heart fatty acid-binding protein to chromosome 1p32-1p33. Hum Genet 1993;92:563-566.
24. Fournier NC, Richard MA: Role of fatty acid binding protein in cardiac fatty acid oxidation. Mol Cell Biochem 1990;90:149-159.
25. Lamers JM, Hulsmann WC: Inhibition of (Na-K) stimulated ATPase of heart by fatty acids. J Mol Cell Cardiol 1977;9:343-346.
26. Liedtke AJ, Nellis S, Neely JR: Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine. Circ Res 1978;4:652-661.
27. Opie LH, Tansey M, Kennelly BM: Proposed metabolic vicious circle in patients with large myocardial infarctions and high plasma-free-fatty-acid concentrations. Lancet 1977;2:890-892.
28. 2+ pearmeability of cardiac sarcolemmal vesicles. J Biol Chem 1985;260:9666-9671.
29. Knowlton AA, Apstein CS, Saouf R, Brecher P: Leakage of heart fatty acid-binding protein with ischemia and reperfusion in the rat. J Mol Cell Cardiol 1989;21:577-583.
30. Offner GD, Brecher P, Sawlivich WB, Costello CE, Troxler RF: Characterization and amino acid sequence of a fatty acid binding protein from human heart. Biochem J 1988;252:191-198.
31. Bass NM, Manning JA: Tissue expression of three structurally different fatty acid binding proteins from ratheart, muscle, liver, and intestine. Biochem Biophys Res Commun 1986;137:929-935.
32. Crisman TS, Claffey KB, Saouaf R, Hanspal J, Brecher P: Measurement of rat heart fatty acid binding protein by ELISA. Tissue distribution, developmental changes and subcellular distribution. J Mol Cell Cardiol 1987;19:423-431.
33. Peeters RA, In't GMA, Veerkamp JH: Fatty acid binding protein from human skeletal muscle. Arch Biochem Biophys 1989;274:556-563.
34. Glatz JF, Paulussen RJ, Veerkamp JH: Fatty acid binding protein from the heart. Chem Phys Lipids 1985;38:115-129.
35. Unteberg C, Heidl G, Von Bassewitz DB, spencer F: Isolation and characterization of the fatty acid binding protein from human heart. J Lipid Res 1986;27:1287-1293.
36. Tank PA, Pomp D: Rapid communication: polymorphism in a bovine heart fatty acid binding protein like (H-FABP) DNA-sequence. J Anim Sci 1995;73:919.
37. Said B, Shulz H: Fatty acid binding protein from rat muscle. Fed Proc 1986;44:1415.
38. Claffey KP, Herrera VL, Brecher P, Ruiz-Opazo N: Cloning and tissue distribution of rat heart fatty acid binding protein mRNA: identical forms in heart and skeletal muscle. Biochemistry 1987;26:7900-7904.
39. Peeters RA, Veerkamp JH, Kanda T, Ono T, Van Kessel AD: Cloning of the cDNA encoding human skeletal muscle fatty acid binding protein, its peptide sequence and chromosomal localization. Biochem J 1991;276:203-207.
40. Sohmiya K, Tanaka T, Tsuji R, et al: Plasma and urinary heart type cytoplasmatic fatty acid binding protein in coronary occlusion and reperfusion induced myocardial injury model. J Mol Cell Cardiol 1993;25:1413-1426.
41. De Winter RJ, Lijmer JG, Koster RW, Hoek FJ, Sanders GT: Diagnostic accuracy of myoglobin concentration for the early diagnosis of acute myocardial infarction. Ann Emerg Med 2000;35:113-120.
42. Stork TV, Wu AH, Muller-Bardorff M, et al: Diagnostic and prognostic role of myoglobin in patients with suspected acute coronary syndrome. North-Wurttemberg Infarction Study (NOWIS) group. Am J Cardiol 2000;86:1371-1374.
43. Panteghini M, Apples FS, Christenson RH, Dati F, Mair J, Wu AH: Proposals from IFCC Committee on standardization of Markers of Cardiac Damage in acute coronary syndromes. Scand J Clin Lab Invest 1999;59(suppl 230):103-112.
44. Wu Ah, Apples FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr: National academy of clinical biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery disease. Clin Chem 1999;45:1104-1121.
45. Van Nieuwenhoven FA, Kleine AH, Wodzig KW, et al: Discrimination between myocardium and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995;92:2848-2854.
46. Kratgen JA, Van Nieuwenhoven FA, Van Dieijen-Visser MP, Theunissen PH, Hermens WT, Glatz JF: Distribution of myoglobin and fatty acid binding protein in human cardiac autopsies. Clin Chem 1996;42:337-338.
47. Gornall DA, Roth SN: Serial myoglobin quantitation in the early assessment of myocardial damage: a clinical study. Clin Biochem 1996;29:379-384.
48. Isakov A, Shapira I, Burke M, Almong C: Serum myoglobin levels in patients with ischemic myocardial insult. Arch Intern Med 1988;148:1762-1765.
49. Kagen L, Scheidt S, Roberts L, Porter A, Paul H: Myoglobinemia following acute myocardial infarction. Am J med 1975;58:177-182.
50. McComb JM, McMaster EA, MacKenzie G, Adgey AA: Myoglobin and creatine kinase in acute myocardial infarction. Br Heart J 1984;51:189-194.
51. Stone MJ, Waterman MR, Harimoto D, et al: Serum myoglobin level as diagnostic test in patients with acute myocardial infarction. Br Heart J 1977;39:375-380.
52. Vaidya HC: Myoglobin: an early biochemical marker for the diagnosis of acute myocardial infarction. J Clin Immunoassay 1994;17:35-39.
53. Bhayana V, Cohoe S, Pellar TG, Jablonsky G, Henderson AR: Combination (multiple) testing for myocardial infarction using myoglobin, creatine kinase 2 (mass)and troponin T. Clin Biochem 1994;27:395-406.
54. de Groot NJ, Uijtiens AM, Simoons ML, Hermens WT, Glatz JF: Assesssment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentration in plasma. Heart 2001;85:278-285.
55. Haastrup B, Gill S, Kristensen SR, Jorgensen PJ, Glatz JF, et al: Biochemical marker of ischemia for the early identification of acute myocardial infarction without ST segment elevation. Cardiology 2000;94:278-285.
56. Ishii J, Wang JH, Naruse H, et al: Serum concentration of myoglobin vs. human heart-type cytoplasmic fatty acid binding protein in the early detection of acute myocardial infarction. Clin Chem 1997;43:1372-1378.
57. Nakata T, Hashimoto A, Hase M, Tsuchihashi K, Shimamoto K: Human heart type fatty acid binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology 2003;99:96-104.
58. Furuhashi M, Ura N, Hasegawa K, Tsuchihashi K, Nakata T, Shimamoto K: Utility f serum ratio of heart type fatty acid binding protein to myoglobin for cardiac damage regardless of renal dysfunction. Circ J 2004;68:656-659.
59. Van Nieuwenhoven FA, Kleine AH, Keizer HA, Van Dieijen-Visser MP, Van der Vusse GJ, Glatz JF: Comparison of myoglobin and fatty acid binding protein as plasma markers for muscle damage in man. Eur J Physiol 1992;421:R40.
60. Wodzig KW, Pelsers MM, Van der Vusse GJ, Roos W, Glatz JF: One-step enzyme-liked immunosorbent assay (ELISA) for plasma fatty acid binding protein. Ann Clin Biochem 1997;34:263-268.
61. Ohkaru Y, Asayama K, Ishii H, et al: Development of a sandwich enzyme-linked-immunosorbent-assay for the determination of human heart type fatty-acid binding protein in plasma and urine by using 2 different monoclonal-antibodies specific for human heart fatty acid binding protein. J Immunol Methods 1995;178:99-111.
62. Roos W, Eymann E, Symannek M, et al: Monoclonal antibodies to human heart fatty acid-binding protein. J Immunol Methods 1995;183:149-153.
63. Watanabe T, Ohkaru Y, Matsuoka H, et al: Development of a single whole blood panel test for detection of human heart type fatty acid binding protein. Clin Biochem 2001;34:257-263.
64. Renneberg R, et al: Novel immunosensors for rapid diagnosis of acute myocardial infarction: a case report. Adv Biosens 1999;4:241-272.
65. Takeshita H, Nishida H, Horinouchi K, et al: Clinical usefulness of a whole blood panel test for rapid detection of human heart-type fatty acid binding protein (Japanese). Jpn J Med Technol 2001;50:91-96.
66. Tanaka T, Hirota Y, Sohimiya K, Nishimura S, Kawamura K: Serum and urinary human heart fatty acid binding protein in acute myocardial infarction. Clin Biochem 1991;24:195-201.
67. Tsuji R, Tanaka T, Sohimiya K, et al: Human heart type cytoplasmic fatty acid binding protein in serum and urine during hyperacute myocardial infarction. Int J Cardiol 1993;41:209-217.
68. Hasegawa T, Yoshimura N, Oka S, et al: Evaluation of heart fatty acid binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2004;127:1697-1702.
69. Nachlas MM, Shnitka TK: Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am J Pathol 1963;42:379-397.
70. Kleine AH, Glatz JF, Havenith MG, Van Nieuwenhoven FA: Immunohistochemical detection of very recent myocardial infarctions in humans with antibodies against human-type fatty acid binding protein. Cardiovasc Res 1993;2:63-69.
71. Watanabe K, Wakabayashi H, Veerkamp JH, Ono T, Suzuki K: Immunohistochemical distribution of heart fatty acid binding protein immunoreactivity in normal human tissues and in acute myocardial infarct. J Pathol 1993;170:59-65.
72. Glatz JF, Van Bilsen M, Paulussen RJ, Veerkamp JH. Van der Vusse GJ, Reneman RS: Release of fatty acid binding protein from isolatedrat heart subjected to ischemia and reperfusion or to he calcium paradox. Biochim Biophys Acta 1988;961:148-152.
73. Abe S, Okino H, Lee S, et al: Human heart fatty acid binding protein. A sensitive and specific marker of coronary reperfusion. Circulation 1991;84:II-291.
74. Yoshimoto K, Tanaka T, Somiya K, et al: Human heart type cytoplasmic fatty acid binding protein as an indicator of acute myocardial infarction. Heart Vessels 1995;10:304-309.
75. Kleine AH, Glatz JF, Van Nieuwenhoven FA, Van der Vusse GJ: Release of heart fatty acid binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992;116:155-162.
76. Glatz JF, Van der Vusse GJ, Maessen JG, Van Dieijen-Visser MP, Hermens WT: Fatty acid binding protein as marker of muscle injury: experimental finding and clinical application. Acta Anaesthesiol Scand Suppl 1997;111:292-294.
77. Chan CP, Sanderson JE, Glatz JFC, Cheng WS, Hempel A, Renneberg R: A superior early myocardial infarction marker: human heart type fatty acid binding protein. Z Kardiol 2004;93:388-397.
78. Bakker AJ, Koelemay MJ, Gorgels JP, et al: Failure of new biochemical markers to exclude acute myocardial infarction at admission. Lancet 1993;242:1220-1222.
79. Volders PG, Vork MM, Glatz JF, Smits JF: Fatty acid binding proteinuria diagnoses myocardial infarction in the rat. Mol Cell Biochem 1993;123:185-190.
80. Gorski J, Hermens WT, Borawski J, Mysliwiec M, Glatz JFC: Increased fatty acidbinding protein concentration in plasma of patients with chronic renal failure. Clin Chem 1997;43:193-195.
81. Nayashida N, Chihara S, Tayama E, Akasu K, Kai E, Kawara T, Aoyagi S: Influence of renal function on serum and urinary heart fatty acidbinding protein levels. J Cardiovasc Surg 200142:735-740.
82. Paulussen RJ, van Moerkerk HT, Veerkamp JH: Immunochemical quantitation of fatty acid binding proteins. Tissue distribution of liver and heart FABP types in human and porcine tissues. Int J Biochem 1990;22:393-398.
83. Alhadi HA, Fox KA: Do we need additional markers of myocyte necrosis: the potential value of heart fatty acid binding protein. Q J Med 2004;97:187-198.
84. Glatz JF, Kleine AH, Kleine AH, Van Nieuwenhoven FA, Hermens WT, Keizer HA, Van Dieijen-Visser MP, Van der Vusse GJ: Fatty acid binding as a plasma marker for the estimation of myocardial infarct size in humans. Br Heart J 1994;71:135-140.
85. Suzuki K, Sawa Y, Kadoba K, Takahashi T, Ichikawa H, Kagisaki K, et al: Early detection of cardiac damage with heart fatty acid-binding protein after cardiac operations. Ann Thorac Surg 1998;65:54-58.
86. Fransen EJ, Maessen JG, Hermens WT, Glantz JF, Buurman WA: Perioperative myocardial tissue injury and the release of inflammatory mediators in coronary artery bypass graft patients. Cardiovasc Res 2000;45:853-859.
87. Hayashida N, Chihara S, Akasu K: Plasma and urinary levels of heart fatty acid binding protein in patients undergoing cardiac surgery. Jpn Circ J 2000;64:18-22.
88. Petzold T, Feindt P, Sunderdiek U, Boeken U, Fischer Y, Gams E: Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. Eur J Cardiothorac Surg 2001;19:859-864.
89. Adams JE: Clinical application of markers of cardiac injury: basic concepts and new considerations. Clin Chim Acta 1999;284:127-134.
90. Hasegawa T, Yoshimura N, Oka S, et al: Evaluation of heart fatty acid binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2004;127:1697-1702.
91. Toyoda Y, Yamaguchi M, Yoshimura N, Oka S, Okita Y: Cardioprotective effects and the mechanisms of terminal warm blood cardioplegia in pediatric cardiac surgery. J Thorac Cardiovas Surg 2003;125:1242-1251.